An Open Label Multicenter Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of SBC-102 in Adult Subjects with Liver Dysfunction Due to Lysosomal Acid Lipase Deficiency Who Previously Received Treatment in Study LAL-CL01
|Effective start/end date||4/18/12 → 3/14/18|
- SYNAGEVA BIOPHARMA CORP.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.